Cincinnati, OH-based CincyTech, a seed stage investor and venture development organization, has announced that its fourth fund, the biggest to date, has closed $30.75 million. It will reportedly be used to invest in around 25 new digital and life science companies.
The private investment for Fund IV is comprised of $20.75 raised by CincyTech in combination with a $10 million loan from Ohio Third Frontier. Total participation in the fund includes 79 individual investors and 12 different institutions.
Cincinnati Children’s Hospital Medical Center, Castellini Management Company, Interact for Health, The Greater Cincinnati Foundation, Western & Southern Financial Group, and UC Health are among those participating institutions.
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
According to the company’s portfolio, it is currently investing in 35 different companies, 10 of which are life sciences companies, the rest being tech.
One life sciences company in the mix is Assurex Health, which develops pharmacogenomics technology to help providers with decision making for behavioral health and chronic pain conditions.
Another is Eccrine Systems, which claims its disposable sweat-monitoring device can constantly test sweat to provide insights into the human body it will then transmit wirelessly into the cloud.
Midwest companies tend to have a harder time attracting venture capital, so CincyTech’s specified Ohio focus allows for many of these companies to have a greater opportunity for growth and development.
Photo: Flickr user bscalled